Cataract Surgery Program at Vance Thompson Vision

Vance Thompson Vision is currently recruiting for the following studies. The descriptions below highlight which patients within your program might be good candidates for the treatment types currently under investigation by Vance Thompson Vision and monitored by the FDA. For questions about any of these trials please call our Director of Research Keeley Puls at 605.371.7075


Cataract Research

Sonata

Good Candidate: Patient who is ready to undergo cataract surgery and are willing to have standard cataract surgery or and upgraded lens.

About: This is a 6 month randomized study comparing the Next-Generation TECNIS Symfony IOL Model ZHR00 to a monofocal ZCB00.

Which Eye? Both eyes will be implanted.

Is there a cost? Cataract surgery is billed to insurance as a standard lens with possible upgrade package free of charge. Patients will also receive a laser fine tune, free of charge, at 6 months.

Compensation: Subjects will be compensated for their participation in this study.

Co-Management? This study is not able to be co-managed, but the subjects can return to you after the 6 month study.

Carl Zeiss IOL

Good Candidate: Patient who is ready to undergo cataract surgery. Subjects must be willing to have standard cataract surgery not an upgraded package.

About: This is a 12 month study for the CT LUCIA 611P Monofocal IOL.

Which Eye? Only one eye will be implanted.

Is there a cost? Cataract surgery is billed to insurance as normal.

Compensation: Subjects will be compensated for their participation in this study.

Co-Management? This study is not able to be co-managed, but the subjects may still return to you for their glasses prescriptions.

B+L Dvisc

Good Candidate: Patient who is ready to undergo cataract surgery. Looking for subjects with 20/200 BCVA or better in at least one eye and otherwise pristine eyes.

About: The study compares different Viscosurgical Devices. The subject can choose any IOL.

Which Eye? Both eyes.

Is there a cost? Cataract surgery is billed to insurance as normal, but the investigational product will be free of charge.

Compensation: Subjects will be compensated for their participation in this study.

Co-Management? This study is not able to be co-managed, but the subjects may still return to you for their glasses prescriptions.

Glaucoma Research

DES / iStent FDA monitored clinical trial

Good Candidates: Patients who are ready to undergo cataract surgery that have mild to moderate glaucoma. Subjects may have either standard or advanced cataract surgery.

About: This study will evaluate if use of the iStent during cataract surgery will have a positive impact on the dryness of the surface of the eye due to fewer glaucoma drops.

Which Eye? Both eyes will be enrolled in the study.

Is there a Cost? There is no additional cost to the patients. Patients will be responsible for normal Cataract surgery charges.

Compensation: Subjects will also be compensated for their participation in the study.

Co-Management? This study is not able to be co-managed, but the subjects may return to you for glasses prescriptions and follow up visits after study completion.

Glaukos GC-010 phase III FDA monitored clinical trial

Good Candidates: Patients that are ocular hypertensive or have mild to moderate glaucoma and will not need cataract surgery in the next three years or have had cataract surgery and no prior glaucoma surgery.

About: This is a randomized study with 2 of 3 subjects receiving the iDose implant with either a high or low eluding dose of Travaprost. The 3rd subject will be considered a placebo that will use drops of timolol twice a day. This is a 3 year study.

Which Eye? Only one eye is eligible to participate in the study.

Is there a Cost? Subjects will not be charged for the idose or timolol.

Compensation: Subjects will also be compensated for their participation in the study.

Co-Management? This study is not able to be comanaged, but the subjects may still return to you for glasses prescriptions.

Aphakic Research

Artisan Aphakia IOL phase III FDA monitored clinical trial

Good Candidates: Patient who is aphakic and has a compromised capsular bag

About: This is a lens that is attached directly to the iris stroma allowing it to sit flush with the iris while maintaining a distance from the delicate structures of the anterior chamber.

Which Eye? Both eyes are eligible to participate in the study.

Is there a cost? The patient will be responsible for a surgery fee but there will not be a charge for the lens.

Compensation: None

Co-Management? This study is not able to be co-managed, but the subjects may still return to you for glasses prescriptions.

Presbyiobic Research

None at this time

Refractive Research

Alcon UV-Femtosecond Laser Assisted Lenticular Extraction - Early Feasibility, Clinical Investigation of the WaveLight Ultraviolet Femtosecond Laser System

Good Candidate: Patients with BCVA of 20/400 or worse with no corneal issues.

About: This is an early feasibility study of the Alcon UV-Femto laser to prove safety of the procedure. Patients will be seen for 7 visits over 6 months.

Which Eye? Only one eye will be enrolled in this study.

Is there a cost? There is no cost to the patient.

Compensation: Patients will be compensated for their participation in this study.

Co-Management? Non co-managed.

Dry Eye Research

TearSolutions Sjogren's Dry Eye

Good Candidate: Patients who have been diagnosed with Primary Sjogren's Syndrome with accompanying lab results, no other autoimmune disorders. No Restasis or Xiidra for 60 days, no allergy medicine for 30 days.

About: This study is testing new eye drops to treat dry eye symptoms by delivering Lacripep, a protein found to be deficient or absent in tear film of people with dry eyes. Patients will be randomly assigned to one of three groups - Control (placebo, receiving artificial tears), and one of two concentrations of study drops.

Which Eye? Both eyes will be treated

Is there a cost? No cost to the patient

Compensation: Subjects will be compensated for their participation in this study.

Co-Management? This study can be co-managed in between appointments, but patient must return to Vance Thompson Vision for 5 visits over 8 weeks.

Olympia

Good Candidate: Patients looking for a possibe treatment for dry eyes.

About: This is but similar to LipiFlow but instea of a one-size-fits-all approach, it is more of a customized approach. Subjects will be randomized to either the treatment or warm compresses and followed for 1 year.

Which Eye? Both eyes.

Is there a cost? Sujects will not be charged for the procedure.

Compensation: Patients will be compensated for their participation in this study.

Co-Management? Non co-managed.

Cornea Research

Avedro KXL

Good Candidate: Patients who have been diagnosed with progressive keratoconus within the last year.

About: This is an epithelium on study for patients with progressive keratoconus randomized in a 2:1 ratio - treatment to sham. If a subject is randomized to the sham group, they can be treated after 6 months.

Which Eye? One or both eyes.

Is there a cost? Sujects will not be charged for the procedure.

Compensation: Patients will be compensated for their participation in this study.

Co-Management? Non co-managed.